A 41-year-old woman with Long-COVID reportedly experienced significant symptom relief after using psilocybin and MDMA, but the effectiveness and safety of these psychedelics for Long-COVID remain uncertain and require further research.
MDMA enhances positive responses to social feedback without affecting negative responses. This sheds light on MDMA's potential in treating social processing impairments, spotlighting its unique empathogenic effects.
Interviews with clinicians reveal potential benefits of MDMA-assisted therapy for Borderline Personality Disorder (BPD), suggesting similarities with PTSD treatment. The study, published in the Journal of Psychedelic Studies, calls for further research into MDMA's efficacy for BPD.
Low doses of MDMA may reduce challenging effects of LSD and psilocybin, increasing positive experiences like love and self-compassion, according to Scientific Reports. This supports the therapeutic potential of "candy flipping" and "hippy flipping."
MDMA-assisted therapy shows promise in enhancing emotional awareness and self-compassion in PTSD patients, areas typically unresponsive to conventional treatments.
New research in the European Journal of Psychotraumatology shows the therapeutic relationship's strength is key in MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD), indicating better outcomes with a stronger alliance.
A study published in Nature Medicine shows MDMA-assisted therapy significantly reduces symptoms in individuals with severe PTSD, offering promising results for those unresponsive to traditional treatments, and is well-tolerated with few side effects.
Researchers have uncovered surprising findings about the effects of two commonly known drugs, MDMA (commonly referred to as ecstasy) and methamphetamine, on human connection and feelings of closeness with conversation partners. Contrary to expectations, both drugs were found to enhance...
An open label study of a group of individuals suffering from posttraumatic stress disorder (PTSD) who also reported suffering chronic pain showed that MDMA-assisted therapy led to significant reduction in pain intensity and pain-related disability in participants with highest levels...
It is widely known that doing drugs can cause neurological impairments, but it can be difficult to know why. A study published in NeuroImage: Clinical provides evidence that chronic MDMA may not cause white matter lesions that are seen from...
Post-traumatic stress disorder (PTSD) is a mental health condition that can occur following exposure to a traumatic or repeated stressful events. It is commonly experienced by military veterans and first responders. While available treatments may not work for everyone, recent...
A study of a large, nationally representative sample of U.S. adults has revealed that those who reported lifetime use of ecstasy (i.e., using ecstasy at least once in their life) were less likely to report having difficulty dealing with strangers,...
A new experiment in Japan showed that when mice are exposed to a chronic social defeat stress condition, they develop a number of adverse health conditions. But these adverse health conditions were absent in mice that were repeatedly injected with...
MDMA-assisted therapy reduces eating disorder symptoms in adults with severe posttraumatic stress disorder (PTSD), according to a new study published in the Journal of Psychiatric Research.
The drug MDMA (3,4-methylenedioxymethamphetamine) might not produce depressive "comedowns" when used in a controlled clinical setting, according to new research published in the Journal of Psychopharmacology. The findings offers some initial evidence that declines in mood and cognition in the...